Active Ingredient: NINTEDANIB ESYLATE
Proprietary Name: OFEV
Dosage Form; Route of Administration: CAPSULE; ORAL
Strength: EQ 150MG BASE
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code:
Application Number: N205832
Product Number: 002
Approval Date: Oct 15, 2014
Applicant Holder Full Name: BOEHRINGER INGELHEIM PHARMACEUTICALS INC
Marketing Status:
Prescription
Patent and Exclusivity Information
